Q4 2022 Holdings
Filed 2023-02-14 | 73 holdings | $199.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $42.8M | 2,600,000 | 21.4% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $26.7M | 3,170,872 | 13.4% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $25.1M | 325,000 | 12.6% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $20.3M | 550,000 | 10.2% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $18.2M | 1,971,739 | 9.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $13.6M | 296,000 | 6.8% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $10.4M | 1,369,179 | 5.2% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $10.4M | 900,000 | 5.2% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $9.6M | 650,000 | 4.8% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $7.4M | 1,547,181 | 3.7% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $6.9M | 612,079 | 3.5% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $6.1M | 50,000 | 3.1% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $745.0K | 392,167 | 0.4% |
| Prometheus Biosciences Inc | COM | 74349U108 | $229.9K | 2,090,000 | 0.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $81.5K | 1,576,872 | 0.0% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $64.3K | 2,075,000 | 0.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $63.7K | 6,065,001 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $61.3K | 2,762,115 | 0.0% |
| Aerovate Therapeutics Inc | COM | 008064107 | $57.3K | 1,957,132 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $52.8K | 5,150,000 | 0.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $46.6K | 10,813,246 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $45.1K | 1,895,066 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $35.4K | 1,080,643 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $32.5K | 2,550,000 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $32.1K | 1,100,000 | 0.0% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $30.4K | 3,680,365 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $29.8K | 4,116,949 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $26.3K | 2,946,887 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $25.9K | 200,000 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $25.5K | 1,736,422 | 0.0% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $24.6K | 1,650,000 | 0.0% |
| Rain Oncology Inc | COM | 75082Q105 | $23.8K | 2,978,660 | 0.0% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $22.0K | 2,893,717 | 0.0% |
| Vectivbio Hldg AG | ORD SHS | H9060V101 | $22.0K | 2,536,617 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $21.6K | 110,000 | 0.0% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $20.2K | 322,240 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $18.1K | 400,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $17.0K | 868,550 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $15.6K | 325,000 | 0.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $15.1K | 782,788 | 0.0% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $13.6K | 734,350 | 0.0% |
| Immuneering Corp(IMRX) | CLASS A COM | 45254E107 | $11.1K | 2,286,181 | 0.0% |
| Greenlight Biosciencs Hlds P | COMMON STOCK | 39536G105 | $10.8K | 9,188,659 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $10.0K | 1,087,807 | 0.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $9.2K | 816,460 | 0.0% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $7.7K | 616,786 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $7.1K | 400,000 | 0.0% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $6.9K | 2,118,283 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $6.8K | 350,000 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $6.6K | 700,000 | 0.0% |